Published in PLoS One on April 16, 2014
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Quantitative synthesis in systematic reviews. Ann Intern Med (1997) 11.72
Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol (1995) 9.03
Comparison of two methods to detect publication bias in meta-analysis. JAMA (2006) 7.34
Epidemiology and etiology of gliomas. Acta Neuropathol (2005) 6.14
Molecular pathology of malignant gliomas. Annu Rev Pathol (2006) 4.24
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol (1996) 4.18
Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res (1991) 3.16
Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther (2009) 3.15
Association between functional polymorphism in EGF gene and malignant melanoma. Lancet (2002) 2.48
Primary brain tumours in adults. Lancet (2012) 2.37
Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst (2001) 2.06
Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst (2003) 1.83
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res (2006) 1.64
Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res (1990) 1.54
Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res (2006) 1.52
A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res (2004) 1.48
Role of epidermal growth factor in carcinogenesis. Cancer Res (1986) 1.41
The pathobiology of glioma tumors. Annu Rev Pathol (2010) 1.40
Designer therapies for glioblastoma multiforme. Ann N Y Acad Sci (2008) 1.28
Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res (2007) 1.22
The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumour Biol (1990) 1.13
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet (2007) 1.01
Association between +61G polymorphism of the EGF gene and glioma risk in different ethnicities: a meta-analysis. Tohoku J Exp Med (2010) 0.91
Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas. Neurology (2008) 0.90
Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer (2010) 0.85
A functional +61G/A polymorphism in epidermal growth factor is associated with glioma risk among Asians. PLoS One (2012) 0.85
Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int J Biol Markers (2010) 0.84
Growth factor receptors and their ligands. J Neurooncol (1994) 0.81
Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy. J Cancer Res Clin Oncol (2012) 0.81
Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies. Front Biosci (2003) 0.80
Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma. Tumour Biol (2013) 0.79
Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population. J Int Med Res (2011) 0.79
No association between EGF +61 A/G polymorphism and increased risk of glioma. Int J Biol Markers (2009) 0.79
Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma. Tumour Biol (2013) 0.78
Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients. Genet Mol Res (2012) 0.77
A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population. Genet Test Mol Biomarkers (2011) 0.77